Analystreport

Spero Therapeutics Inc (NASDAQ: SPRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Spero Therapeutics, Inc.  (SPRO) 
Last spero therapeutics, inc. earnings: 3/16 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: investors.sperotherapeutics.com/overview